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Peven-Year Follow-Up
fter Dobutamine Stress Echocardiography
mpact of Gender on Prognosis
lena Biagini, MD,*† Abdou Elhendy, MD, FACC,‡ Jeroen J. Bax, MD,§ Vittoria Rizzello, MD,*
rend F. L. Schinkel, MD,* Ron T. van Domburg, PHD,* Miklos D. Kertai, MD,*
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aarten L. Simoons, MD, FACC,* Don Poldermans, MD*
otterdam and Leiden, the Netherlands; Bologna, Italy; and Omaha, Nebraska
OBJECTIVES The aim of this study was to investigate the effects of gender on long-term prognosis of
patients undergoing dobutamine stress echocardiography (DSE).
BACKGROUND Gender differences in the predictors of outcome among patients with known or suspected
coronary artery disease undergoing DSE have not been adequately studied.
METHODS We studied 2,276 men and 1,105 women with known or suspected coronary artery disease
who underwent DSE. Follow-up events were cardiac death and nonfatal myocardial
infarction (MI).
RESULTS Dobutamine stress echocardiography was normal in 687 men (30%) and 483 women (44%) (p
0.0001). Ischemia on DSE was present in 1,194 men (52%) and 416 women (38%) (p 0.001).
During a mean follow-up of 7 3.4 years, there were 894 (26%) deaths (442 attributed to cardiac
causes) and 145 (4%) nonfatal MIs. The annual cardiac event rate was 2.5% in men and 1.2% in
women with normal DSE. Independent predictors of cardiac events in patients with normal DSE
using a Cox proportional hazards regression analysis were male gender (hazard ratio [HR]: 1.7
[range 1.1 to 2.8]), age (HR: 1.02 [range 1.01 to 1.04]), history of heart failure (HR: 3.4 [range
1.5 to 7.9]), previous MI (HR: 1.7 [range 1.1 to 2.8]), and diabetes (HR: 2.4 [range 1.3 to 4.5]).
Independent predictors of cardiac events in patients with an abnormal DSE were age (HR: 1.03
[range 1.02 to 1.04]), history of heart failure (HR: 1.7 [range 1.3 to 2.1]), diabetes (HR: 1.4 [range
1.1 to 1.8]), heart rate at rest (HR: 2.8 [range 1.4 to 5.8]), wall motion abnormalities at rest (HR:
1.06 [range 1.04 to 1.09]), and ischemia on DSE (HR: 1.04 [range 1.02 to 1.07]). Myocardial
ischemia was an independent predictor of cardiac events in both men and women.
CONCLUSIONS Dobutamine stress echocardiography provides independent prognostic information in both
men and women. In patients with normal DSE, gender is independently associated with
cardiac events. The outcome of patients with abnormal DSE is not related to gender, after
adjusting for stress echocardiographic abnormalities. (J Am Coll Cardiol 2005;45:93–7)
ublished by Elsevier Inc. doi:10.1016/j.jacc.2004.09.048© 2005 by the American College of Cardiology Foundation
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coronary artery disease (CAD) is a leading cause of
ortality and morbidity in industrialized countries, in men
s well as in women (1). Previous studies of the effect of
ender on long-term survival of patients with known or
uspected CAD have yielded conflicting results (2,3). Clin-
cal evaluation of CAD has traditionally been more chal-
enging in women compared with men because of the lower
revalence of the disease, the higher incidence of referral
ias, and the intrinsic performance of various modalities of
tress testing. Dobutamine stress echocardiography (DSE)
as been reported as an effective noninvasive tool in detect-
ng CAD and assessing prognosis in women (4,5). There is
controversy regarding the presence of a gender-based
ifference in the accuracy of DSE in detecting CAD (5–7).
owever, gender differences in the predictors of outcome
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004, accepted September 16, 2004.mong patients with known or suspected CAD undergoing
SE have not been adequately studied. The aims of this
tudy were: 1) to assess the predictors of cardiac death and
onfatal myocardial infarction (MI) during a long-term
ollow-up in men and women referred for DSE for evalu-
tion of MI on DSE; and 2) to find whether gender has an
mpact on outcome after controlling for clinical variables
nd stress echocardiographic data.
ATERIALS AND METHODS
atients. The study population consisted of 3,875 consec-
tive patients with limited exercise capacity and known or
uspected CAD, referred for DSE between January 1990
nd January 2003 at the Thoraxcenter, Rotterdam, the
etherlands. Follow-up was successful in 3,836 patients
99%). A total of 455 patients (12%) underwent early
oronary revascularization in the first 60 days after DSE and
ere excluded from the analysis. The final population
onsisted of 3,381 patients. The protocol was approved by
he Hospital Ethics Committee. All patients gave informed
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Effects of Gender on Prognosis January 4, 2005:93–7onsent before the test. Clinical characteristics and indica-
ions for testing were entered into a computerized database
efore DSE. Known CAD was defined as documentation of
revious MI or myocardial revascularization or angiographic
ocumentation of significant coronary artery stenosis. Sus-
ected CAD was defined as the presence of symptoms
elated to CAD or the evidence of an abnormal baseline
lectrocardiogram associated with the presence of cardiac
isk factors for CAD.
obutamine stress protocol. Low- to high-dose DSE (up
o 40 g/kg/min plus 2 mg atropine, if necessary) was
erformed according to a standard protocol as previously
eported (6). Test end points were achievement of target
eart rate (85% of maximal age- and gender-predicted heart
ate), maximal dose of dobutamine and atropine, extensive
ew wall motion abnormalities, 2 mV downsloping ST-
egment depression measured 80 ms after the J point
ompared with baseline, hypertension (blood pressure
240/120 mm Hg), a decrease in systolic blood pressure of
40 mm Hg compared with at rest, significant arrhythmias,
r any intolerable adverse effect considered to be the result
f dobutamine or atropine.
Table 1. Clinical Characteristics
M
(n 
Age, yrs (SD) 61.
Hypertension (%) 6
Hypercholesterolemia (%) 1,2
Smoking (%) 7
History of typical angina (%) 6
History of atypical angina (%) 3
Diabetes mellitus (%) 3
History of heart failure (%) 1
Previous myocardial infarction (%) 9
Beta-blockers (%) 7
Calcium-channel blockers (%) 5
ACE inhibitors (%) 5
Diuretics (%) 3
Nitrates (%) 7
Indication for DSE
Diagnosis of CAD (%) 1,2
Preoperative evaluation before
non-cardiac surgery (%)
7
Risk stratification after
myocardial infarction (%)
2
Abbreviations and Acronyms
CAD coronary artery disease
DSE  dobutamine stress echocardiography
HR  hazard ratio
MI  myocardial infarctionACE  angiotensin-converting enzyme; CAD  coronary arterychocardiographic imaging and interpretation. Two-
imensional echocardiographic images were acquired at
est, during dobutamine stress, and during recovery using
tandard views. Regional wall motion and systolic wall
hickening were scored on a five-point scale using a standard
6-segment left ventricular model. Ischemia was defined as
ew or worsened wall motion abnormalities during stress
ndicated by an increase of wall motion score 1 grade in
1 segment. A biphasic response in an akinetic or severely
ypokinetic segment was considered as an ischemic re-
ponse. Ischemia was not considered present when akinetic
egments at rest became dyskinetic during stress. For each
atient, a wall motion score index was calculated by dividing
he sum of segment scores by the total number of inter-
reted segments.
ollow-up. Follow-up data collection was performed by
ontacting the patient’s general practitioner and by review of
ospital records. The date of the last review or consultation
as used to calculate follow-up time. Follow-up events
oted were overall mortality and hard cardiac events (non-
atal MI and cardiac death). Myocardial revascularization
rocedures were also noted.
tatistical analysis. Continuous data were expressed as
ean values  SD. The Student t test was used to analyze
ontinuous data and the chi-square test was used for
ifferences between proportions. Univariate and multivari-
te Cox proportional hazard regression models (BMDP
tatistical Software Inc., Los Angeles, California) were used
o identify independent predictors of follow-up events (8).
ariables were selected in a stepwise forward selection
anner with entry and retention set at a significance level of
6)
Women
(n  1,105) p Value
3 60.6  11 0.03
) 401 (36)  0.001
) 733 (66)  0.001
) 241 (22)  0.001
) 286 (26) 0.02
) 289 (26)  0.001
) 133 (12) 0.3
110 (10)  0.001
) 264 (24)  0.001
) 362 (33) 0.8
) 273 (25) 0.6
) 257 (23) 0.1
) 164 (15) 0.4
) 305 (28) 0.01
) 770 (70)  0.0001
) 253 (23)  0.0001
) 84 (8)  0.0001en
2,27
6  1
04 (27
22 (54
47 (33
75 (30
01 (13
34 (15
07 (5)
92 (44
54 (33
43 (24
88 (26
13 (14
26 (32
30 (54
64 (34
80 (12disease; DSE  dobutamine stress echocardiography.
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January 4, 2005:93–7 Effects of Gender on Prognosis.05. The probability of survival was calculated using the
aplan-Meier method, and survival curves were compared
sing the log-rank test. A p value 0.05 was considered
tatistically significant.
ESULTS
atient characteristics and hemodynamic response. Mean
ge was 61  10 years. There were 2,276 men (67%) and
,105 women (33%). Clinical and hemodynamic data are
resented in Tables 1 and 2, respectively. Arrhythmias were
on-sustained ventricular tachycardia in 124 patients (4%),
trial fibrillation in 43 patients (1%), severe hypotension
decrease in systolic blood pressure 40 mm Hg compared
ith baseline) in 33 patients (1%), and ventricular fibrilla-
ion in four patients (0.1%). Defibrillation was successful
nd no electrocardiographic or cardiac enzymatic changes
uggestive of MI were observed in these four patients. The
est was terminated for achievement of the target heart rate
n 3,009 patients (89%), maximal dobutamine/atropine dose
n 101 patients (3%), ST-segment changes in 99 patients
3%), arrhythmias in 30 patients (1%), angina in 40 patients
1%), abnormal blood pressure in 38 patients (1%), and
ther symptoms in 64 patients (2%).
chocardiographic data and outcome. Dobutamine stress
chocardiography was normal in 687 men (30%) and 483
omen (44%) (p 0.0001). Ischemia on DSE was detected
n 1,194 men (52%) and 416 women (38%) (p 0.0001); of
hese patients 1,077 men (47%) and 364 women (33%) had
esting wall motion abnormalities as well (p  0.0001).
During a mean follow-up of 7 3.4 years, there were 894
eaths (26%), of which 442 (13%) were attributed to cardiac
auses (Table 3). Men had a higher annual total mortality
ate (5.7% vs. 3.9%) and cardiac event rate (4.2% vs. 2.6%)
ompared with women (both p  0.0001). Of the 372
atients (11%) who did not reach the target heart rate
able 2. Dobutamine Stress Echocardiographic Data
eart rate at rest (beats/min)
eart rate at peak (beats/min)
est systolic blood pressure (mm Hg)
eak systolic blood pressure (mm Hg)
est rate-pressure product
eak rate-pressure product
aximal dobutamine dose (g/kg/min)
tropine use, patients (%)
ngina during dobutamine stress (%)
T-segment depression (%)
esting wall motion score index
umber of ischemic segments
ormal DSE, patients (%)
esting abnormalities, patients (%)
ew or worsening wall motion abnormalities, patients (%)
esting plus new or worsening wall motion abnormalities, patients (%)
bbreviations as in Table 1.uring DSE, 93 (25%) had normal DSE, 19 (5%) had Cschemia, 74 (20%) had fixed wall motion abnormalities,
nd 186 (50%) had both ischemia and fixed wall motion
bnormalities.
redictive value of clinical data and test results. There
ere 1,170 patients (35%) with normal DSE. Independent
linical predictors of hard cardiac events in these patients
ere male gender (hazard ratio [HR]: 1.7 [range 1.1 to
.8]), age (HR: 1.02 [range 1.01 to 1.04]), history of heart
ailure (HR: 3.4 [range 1.5 to 7.9]), previous MI (HR: 1.7
range 1.1 to 2.8]), and diabetes (HR: 2.4 [range 1.3 to
.5]). Independent predictors of cardiac events in patients
ith abnormal DSE were age (HR: 1.03 [range 1.02 to
.04]), history of heart failure (HR: 1.7 [range 1.3 to 2.1]),
iabetes (HR: 1.4 [range 1.1 to 1.8]), heart rate at rest (HR:
.8 [range 1.4 to 5.8]), wall motion abnormalities at rest
HR: 1.06 [range 1.04 to 1.09]), and ischemia on DSE
HR: 1.04 [range 1.02 to 1.07]).
Univariate and multivariate predictors of hard cardiac
vents evaluated separately in men and women are shown in
ables 4 and 5, respectively. Resting wall motion score
ndex and ischemia on DSE were predictive of cardiac
vents in both genders. Kaplan-Meier survival curves for the
nd point of cardiac death/nonfatal infarction are presented
Men
(n  2,276)
Women
(n  1,105) p Value
72  14 74 14  0.0001
131 15 126 13  0.0001
121 24 125 25  0.0001
146 31 148 27 0.09
9,451 2,497 10,035 2,641  0.0001
19,330 4,544 18,718 3,867 0.0002
36 7 33  9  0.0001
739 (32) 270 (24)  0.0001
420 (18) 148 (13)  0.0001
652 (29) 206 (19)  0.0001
1.5 0.6 1.3 0.5  0.0001
3.6 4.9 2.3 4.1  0.0001
687 (30) 483 (44)  0.0001
395 (17) 206 (19) 0.4
117 (5) 52 (5) 0.6
1,077 (47) 364 (33)  0.0001
able 3. Follow-Up Events in Both Genders
Men
(n  2,276)
Women
(n  1,105) p Value
ll death (%) 678 (30) 216 (20)  0.0001
ardiac death (%) 335 (15) 107 (10)  0.0001
onfatal myocardial
infarction (%)
113 (5) 32 (3) 0.007
ard cardiac events (%) 448 (20) 139 (13)  0.0001
ate revascularization (%) 576 (25) 178 (16)  0.0001
oronary angioplasty (%) 271 (12) 106 (9)  0.0001
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Effects of Gender on Prognosis January 4, 2005:93–7n Figure 1. In patients with normal DSE, the annual hard
ardiac event rate during seven years of follow-up was 2.5%
n men and 1.2% in women (p  0.0001). There was no
ifference in annual hard cardiac event rate between men
nd women with wall motion abnormalities at rest (2.9% vs.
.1%, p  0.1) or men and women with both rest and new
all motion abnormalities (5.9% vs. 4.6%, p 0.3). Survival
urves according to the results of DSE are shown in Figure
(men) and Figure 3 (women).
ISCUSSION
his study demonstrated an independent prognostic value
f DSE for the prediction of cardiac events in both men and
omen during a long-term mean follow-up of seven years.
In patients with normal DSE, male gender remained an
ndependent predictor of cardiac death and nonfatal MI
fter adjustment for other clinical variables. In patients with
bnormal DSE the outcome was related to the severity of
eft ventricular dysfunction and inducible ischemia on DSE,
ut not to the gender. These data indicate that women with
bnormal DSE should be treated as aggressively as men
onsidering the clinical and echocardiographic risk profiles,
s the risk imposed by these parameters was not gender
elated.
The underlying cause for the association of male gender
ith a higher cardiac event rate among patients with normal
SE is not clear. One explanation could be a gender-related
ifference in the prevalence and/or progression of non-
bstructive coronary arterial lesions that were not severe
able 4. Univariate Predictors of Hard Cardiac Events
Model HR 95%
moking 1.4 1.1
istory of heart failure 3.6 2.7
iabetes mellitus 1.4 1.0
revious myocardial infarction 2.1 1.7
T-segment depression 1.6 1.3
arget heart rate
all motion score index at rest 2.36 2.24
bnormal segments at rest 1.7 1.4
ew or worsening wall motion abnormalities 1.6 1.3
I  confidence interval; HR  hazard ratio.
able 5. Multivariate Predictors of Hard Cardiac Events
Model HR 95%
ge* 1.03 1.02
moking 1.2 1.0
istory of heart failure 1.7 1.4
iabetes mellitus 1.4 1.1
eart rate at rest 2.4 1.1
all motion score index at rest 1.7 1.4
ew or worsening wall motion abnormalities 2.2 1.7Hazard ratios referred per year of age.
Abbreviations as in Table 4.nough to induce ischemia on DSE in the group with
ormal DSE. Another explanation could be a gender
ifference in the diagnostic accuracy of DSE, with some
tudies showing a better accuracy of DSE in women than in
en (6). However, there is controversy among published
eports regarding this issue, with some studies reporting
etter accuracy in men (7) and others reporting similar
ccuracy in both genders (5).
The association of higher heart rate at rest with adverse
utcome may be related to onset of autonomic dysfunction
s an early compensatory mechanism with incipient heart
ailure (9). Some investigators suggested that sympathetic
veractivity could be the common factor acting on choles-
erol, heart rate, pulse pressure, and arterial stiffness with
ubsequent increase in cardiac workload (10,11).
omparison with previous studies. Data in published
eports regarding the impact of gender on long-term prog-
osis of patients with CAD are inconsistent. Few studies
ave specifically focused on gender differences in the pre-
ictors of outcome after noninvasive stress testing. Al-
hough some of these studies showed incremental prognos-
ic value of stress imaging techniques in both genders, most
f these studies did not specifically address the impact of
ender on survival after adjusting for other clinical and stress
maging parameters (12–14).
tudy limitations. Patients with chronic non-cardiac dis-
ases such as end-stage renal disease or chronic obstructive
ulmonary disease were not excluded from the study. These
atients may be at a higher risk for cardiac death despite a
Women
p Value HR 95% CI p Value
0.0008
 0.0001 3.5 2.1–5.8  0.0001
0.01 1.8 1.1–3.0 0.005
 0.0001 3.7 2.6–5.4  0.0001
 0.0001
1.6 1.1–2.3 0.01
 0.0001 3.70 2.85–4.70  0.0001
 0.0001 2.2 1.5–3.2  0.0001
 0.0001 2.4 1.7–3.6  0.0001
Women
p Value HR 95% CI p Value
 0.0001 1.09 1.04–1.2  0.0001
0.05
0.005
0.04
0.02
 0.0001 4.3 2.8–6.7 0.001
 0.0001 3.2 1.7–6.3 0.0003Men
CI
–1.7
–4.8
–1.9
–2.5
–2.0
–2.93
–2.2
–2.0Men
CI
–1.04
–1.5
–2.3
–1.9
–5.1
–2.0
–2.9
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January 4, 2005:93–7 Effects of Gender on Prognosisegative stress test for ischemia. Patients enrolled in January
003 had a short follow-up period. Finally, the study
nrolled patients over 13 years with implementation of new
hanges in imaging such as second harmonic imaging and
yocardial contrast overtime. Differences in accuracy re-
ated to the use of these methods may have had an impact
n the results.
linical implications and conclusions. Dobutamine
tress echocardiography provides independent prognostic
nformation for the prediction of cardiac events during
ong-term follow-up in both genders. The prognosis after a
ormal DSE is more favorable in women than in men, after
orrection for clinical variables. The outcome of patients
ith abnormal DSE is related to severity of left ventricular
ysfunction and ischemia on DSE, but not related to gender
fter adjusting for other variables. Therefore, women with
bnormal DSE should be treated as aggressively as men,
ecause the risk imposed by echocardiographic abnormali-
ies is not gender related.
igure 1. Kaplan-Meier survival curves (end point of hard cardiac events)
n men and women with normal dobutamine stress echocardiography.
igure 2. Kaplan-Meier survival curves (end point of hard cardiac events)
n men according to results of dobutamine stress echocardiography.eprint requests and correspondence: Dr. Don Poldermans, De-
artment of Cardiology, Thoraxcenter Room Ba 300, Erasmus MC,
r. Molewaterplein 40, 3015 GD Rotterdam, the Netherlands.
-mail: d.poldermans@erasmusmc.nl.
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